Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies
- DOI
- 10.3324/haematol.2026.300977
- Published
- 2026-09-24
- Container
- Haematologica
- Publisher
- Ferrata Storti Foundation (Haematologica)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2026.300977,
title = {Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies},
author = {Anna Guidetti and Irene Dogliotti and Annalisa Chiappella and Emilio Iannitto and Andrea Evangelista and Anna Dodero and Alice Di Rocco and Monica Balzarotti and Beatrice Casadei and Federica Cavallo and Alessandro Re and Mirko Farina and Stefania Bramanti and Patrizia Chiusolo and Massimo Martino and Maurizio Musso and Manuela Zanni and Giovanni Grillo and Emanuele Ravano and Mauro Krampera and Stefan Hohaus and Maurizio Martelli and Giulia Zacchi and Carlo Visco and Pier Luigi Zinzani and Ugo Consoli and Paolo Corradini},
year = {2026},
journal = {Haematologica},
doi = {10.3324/haematol.2026.300977},
url = {https://doi.org/10.3324/haematol.2026.300977}
}RIS
TY - JOUR TI - Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies AU - Anna Guidetti AU - Irene Dogliotti AU - Annalisa Chiappella AU - Emilio Iannitto AU - Andrea Evangelista AU - Anna Dodero AU - Alice Di Rocco AU - Monica Balzarotti AU - Beatrice Casadei AU - Federica Cavallo AU - Alessandro Re AU - Mirko Farina AU - Stefania Bramanti AU - Patrizia Chiusolo AU - Massimo Martino AU - Maurizio Musso AU - Manuela Zanni AU - Giovanni Grillo AU - Emanuele Ravano AU - Mauro Krampera AU - Stefan Hohaus AU - Maurizio Martelli AU - Giulia Zacchi AU - Carlo Visco AU - Pier Luigi Zinzani AU - Ugo Consoli AU - Paolo Corradini PY - 2026 JO - Haematologica DO - 10.3324/haematol.2026.300977 UR - https://doi.org/10.3324/haematol.2026.300977 ER -
APA
Guidetti, A., Dogliotti, I., Chiappella, A., Iannitto, E., Evangelista, A., Dodero, A., Rocco, A. D., Balzarotti, M., Casadei, B., Cavallo, F., Re, A., Farina, M., Bramanti, S., Chiusolo, P., Martino, M., Musso, M., Zanni, M., Grillo, G., Ravano, E., Krampera, M., Hohaus, S., Martelli, M., Zacchi, G., Visco, C., Zinzani, P. L., Consoli, U., & Corradini, P. (2026). Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies. Haematologica. https://doi.org/10.3324/haematol.2026.300977
Source records
- crossref · retrieved 2026-09-27T02:23:13.971Z